JANE STREET GROUP, LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,776,856
-55.7%
125,581
-54.5%
0.00%
-57.1%
Q2 2023$19,826,317
+1378.3%
275,902
+1168.9%
0.01%
+600.0%
Q1 2023$1,341,170
-90.1%
21,744
-87.6%
0.00%
-83.3%
Q4 2022$13,567,090
+66.3%
175,899
-3.8%
0.01%
+50.0%
Q3 2022$8,159,000
+408.7%
182,870
+336.5%
0.00%
+300.0%
Q2 2022$1,604,000
-79.0%
41,895
-77.3%
0.00%
-66.7%
Q1 2022$7,652,000
-81.4%
184,859
-83.0%
0.00%
-78.6%
Q4 2021$41,049,000
+71.1%
1,086,494
+49.3%
0.01%
+75.0%
Q3 2021$23,989,000
-14.7%
727,832
+74.5%
0.01%
-27.3%
Q2 2021$28,139,000
+5.0%
417,111
-11.8%
0.01%
-15.4%
Q1 2021$26,791,000
-10.4%
473,172
+28.9%
0.01%
-13.3%
Q4 2020$29,896,000
-36.3%
366,954
-44.3%
0.02%
-48.3%
Q3 2020$46,901,000
+6.2%
658,255
+22.7%
0.03%
-12.1%
Q2 2020$44,154,000
+148.4%
536,639
+77.6%
0.03%
+94.1%
Q1 2020$17,776,000
-37.2%
302,160
+10.3%
0.02%
-56.4%
Q4 2019$28,306,000
+11132.5%
273,856
+2099.6%
0.04%
Q3 2019$252,000
-18.7%
12,450
+3.3%
0.00%
-100.0%
Q2 2019$310,000
-66.0%
12,058
-81.2%
0.00%0.0%
Q1 2019$913,00064,1500.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders